• OPEN AN ACCOUNT
Indian Indices
Nifty
25,541.80 24.75
(0.10%)
Sensex
83,643.74 -53.55
( -0.06%)
Bank Nifty
57,459.45 146.70
( 0.26%)
Nifty IT
38,833.15 -116.85
( -0.30%)
Global Indices
Nasdaq
44,512.09 396.31
(0.90%)
Dow Jones
6,218.43 -7.52
(-0.12%)
Hang Seng
39,928.49 -558.90
(-1.38%)
Nikkei 225
8,785.33 24.37
(0.28%)
Forex
USD-INR
85.62 0.21
(0.25%)
EUR-INR
100.54 0.47
(0.47%)
GBP-INR
117.42 0.25
(0.22%)
JPY-INR
0.59 0.00
(0.57%)

EQUITY - MARKET SCREENER

Sun Pharmaceutical Industries Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
524715
INE044A01036
101.444166
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
SUNPHARMA
93.4
400017.13
EPS(TTM)
Face Value()
Div & Yield %
17.85
1
0.96
 

Elitecon International standalone net profit rises 93.81% in the March 2025 quarter
May 28,2025
Net profit of Elitecon International rose 93.81% to Rs 12.21 crore in the quarter ended March 2025 as against Rs 6.30 crore during the previous quarter ended March 2024. Sales rose 170.65% to Rs 120.41 crore in the quarter ended March 2025 as against Rs 44.49 crore during the previous quarter ended March 2024.

For the full year,net profit rose 573.85% to Rs 32.21 crore in the year ended March 2025 as against Rs 4.78 crore during the previous year ended March 2024. Sales rose 423.60% to Rs 297.51 crore in the year ended March 2025 as against Rs 56.82 crore during the previous year ended March 2024.

ParticularsQuarter EndedYear Ended
Mar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var.
Sales120.4144.49 171 297.5156.82 424
OPM %10.0315.67 -10.6412.78 -
PBDT12.736.38 100 33.936.86 395
PBT12.196.23 96 32.134.65 591
NP12.216.30 94 32.214.78 574